Market Research Logo

Estonia Pharmaceuticals & Healthcare Q4 2018

Estonia Pharmaceuticals & Healthcare Q4 2018

Key View:

We expect growth in Estonia’s pharmaceutical market to remain positive over our forecast period, driven by improvedmedicine reimbursement funding and the reduction of co-payments paid by patients with high drug costs. Over the long-term,patented medicine sales will be supported by an ageing demographic and the high prevalence of cardiovascular disease andcancers. However, multinational drugmakers’ interest in the market will remain limited owing to its small overall size and a decliningpopulation, which restrict growth opportunities.


Key View
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Central And Eastern Europe Innovative Pharmaceuticals Risk/Reward Index
Estonia Innovative Pharmaceuticals Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
Grindeks
Estonia Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report